Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
-
Source:
A Phase III Randomized Trial of Chemotherapy With or Without Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer
تفاصيل العنوان
-
Source:
A Phase II Randomized Trial of Adjuvant Therapy With Pembrolizumab After Resection of Recurrent/Second Primary Head and Neck
تفاصيل العنوان
-
Source:
A Multicenter, Randomized Controlled, Non-inferior Phase 3 Clinical Trial of 2 Courses of Concurrent Cisplatin Chemoradiotherapy Versus 3 Courses After Surgery for High-risk
تفاصيل العنوان
-
Source:
Phase Ib Study of a Monoclonal Antibody to OX40 (MEDI0562) Administered Prior to Surgical Resection in Patients With Head and Neck
تفاصيل العنوان
-
Source:
ARTEMIS-006: A Phase 2 Study to Evaluate Efficacy and Safety of Intravenous Administration of HS-20093 in Patients With Head and Neck
تفاصيل العنوان
-
Authors :
Michael Topf, Assistant Professor of Medicine
-
Source:
Study Evaluating 89Zr Panitumumab for Assessment of Indeterminate Metastatic Lesions on 18F-FDG-PET/CT in Head and Neck
تفاصيل العنوان
-
Source:
An Exploratory Phase II Study of Neoadjuvant Treatment With AK112 Plus AP Regimen for Operable Locally Advanced Head and Neck
تفاصيل العنوان
-
Source:
Pilot Study of INCB081776 Together With Palliative Radiation and Anti-PD-1 Checkpoint Blockade With Pembrolizumab in Patients With Recurrent or Metastatic Head and
تفاصيل العنوان
-
Authors :
Andreas Dietz, Prof. Dr. med.
-
Source:
Postoperative Adjuvant Radiochemotherapy (aRCH) With Cisplatin (C) Versus aRCH With C and Pembrolizumab (P) in Locally Advanced Head and
تفاصيل العنوان
-
Source:
A Randomized, Controlled, Multicenter Phase 3 Study of AK112 in Combination with AK117 Versus Pembrolizumab As First Line Treatment for a Programmed Cell Death-ligand 1
تفاصيل العنوان